Bearish flow noted in GSK (GSK) Pharma with 5,611 puts trading, or 3x expected. Most active are Mar-25 36.5 puts and 3/14 weekly 39.5 calls, with total volume in those strikes near 6,100 contracts.

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...

This is the second partnership signed by GSK in neuroscience in the last few weeks, coming after it teamed up with Vesalius Therapeutics on a potential small-molecule therapy for Parkinson's ...

Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...

Shortly after the re-release of the Mediterranean-inspired map, an explosion rocked the island, creating a series of cracks and crevices throughout while opening up a new underground area.

© 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...

NPR's Up First is the news you need to start your day. The three biggest stories of the day, with reporting and analysis from NPR News — in 10 minutes. Available weekdays at 6:30 a.m. ET ...

This public frenzy has unlocked a flood of investment from venture capitalists—funding for longevity startups is up by 75% over the ... his first venture, which GSK bought in 2008, to develop ...